Safety study of SEP-363856 in schizophrenia
This study is completed in the United States. It is testing SEP-363856 for schizophrenia.
Multiple locations, including GlendaleThis study is directly about Schizophrenia.

Compare studies and check their requirements with the research team.
This study is completed in the United States. It is testing SEP-363856 for schizophrenia.
Multiple locations, including GlendaleThis study is directly about Schizophrenia.
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listedThis study is directly about Schizophrenia.
This summary needs review. Please check the official study record and contact the research team for details.
In RockvilleThis study is directly about Schizophrenia.
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Little RockThis study is directly about Schizophrenia.
This summary needs review. Please check the official study record and contact the research team for details.
In HoustonThis study is directly about Schizophrenia.
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Tokyo, Etc.This study is directly about Schizophrenia.
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Garden GroveThis study is directly about Schizophrenia.
This study is completed in the United States. It is testing Systemic and Ocular Safety and Pharmacokinetics of BI 409306 for schizophrenia.
Multiple locations, including La JollaThis study is directly about Schizophrenia.
This study is completed in France. It is testing impact on the Therapeutic Alliance of a Short Initial Psychoeducation Programme for schizophrenia.
In NiceThis study is directly about Schizophrenia.
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including ChandlerThis study is directly about Schizophrenia.
This study was terminated in Japan and in Taiwan. It is testing adverse Events and Change for schizophrenia.
Multiple locations, including AkitaThis study is directly about Schizophrenia.
This study is completed in the United States. It is testing Slowly Increasing Dose and Food Effect of KarXT for schizophrenia.
Multiple locations, including Los AlamitosThis study is directly about Schizophrenia.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.